L C Quilty1, C McBride, R M Bagby. 1. Clinical Research Department, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, Canada.
Abstract
BACKGROUND: Although empirical support for the efficacy of cognitive behavioural therapy (CBT) as a treatment for major depressive disorder (MDD) is well established, its mechanism of action is uncertain. In this investigation, we examined evidence for the cognitive mediational model in a randomized control trial involving CBT, interpersonal therapy (IPT) and pharmacotherapy (PHT) in patients with MDD. METHOD: One hundred and thirty participants diagnosed with MDD were treated with CBT, IPT or PHT. Participants completed the Hamilton Depression Rating Scale, Beck Depression Inventory-II and Dysfunctional Attitudes Scale prior to and following treatment. RESULTS: The cognitive mediational model, in which dysfunctional attitudes are proposed to mediate depressive symptom reduction in response to treatment, provided a good fit to the data when contrasting CBT v. IPT, with results supporting a mediational role for dysfunctional attitude change in depressive symptom reduction. The complication model, in which dysfunctional attitudes are proposed to be a consequence of depressive symptom reduction, provided a good fit to the data when contrasting CBT v. PHT, with results supporting a mediational role for depressive symptom reduction in dysfunctional attitude change. CONCLUSIONS: There was no evidence for a mediational role for dysfunctional attitude change in IPT. Changes in dysfunctional attitudes accompanied both CBT and PHT; however, empirical evidence suggests that the role of attitudes in treatment outcome may differ between these two treatments.
RCT Entities:
BACKGROUND: Although empirical support for the efficacy of cognitive behavioural therapy (CBT) as a treatment for major depressive disorder (MDD) is well established, its mechanism of action is uncertain. In this investigation, we examined evidence for the cognitive mediational model in a randomized control trial involving CBT, interpersonal therapy (IPT) and pharmacotherapy (PHT) in patients with MDD. METHOD: One hundred and thirty participants diagnosed with MDD were treated with CBT, IPT or PHT. Participants completed the Hamilton Depression Rating Scale, Beck Depression Inventory-II and Dysfunctional Attitudes Scale prior to and following treatment. RESULTS: The cognitive mediational model, in which dysfunctional attitudes are proposed to mediate depressive symptom reduction in response to treatment, provided a good fit to the data when contrasting CBT v. IPT, with results supporting a mediational role for dysfunctional attitude change in depressive symptom reduction. The complication model, in which dysfunctional attitudes are proposed to be a consequence of depressive symptom reduction, provided a good fit to the data when contrasting CBT v. PHT, with results supporting a mediational role for depressive symptom reduction in dysfunctional attitude change. CONCLUSIONS: There was no evidence for a mediational role for dysfunctional attitude change in IPT. Changes in dysfunctional attitudes accompanied both CBT and PHT; however, empirical evidence suggests that the role of attitudes in treatment outcome may differ between these two treatments.
Authors: Charles H Bombardier; Jesse R Fann; Evette J Ludman; Steven D Vannoy; Joshua R Dyer; Jason K Barber; Nancy R Temkin Journal: J Head Trauma Rehabil Date: 2017 Sep/Oct Impact factor: 2.710
Authors: Hannah C Levy; Blaise L Worden; Christina M Gilliam; Christine D'Urso; Gail Steketee; Randy O Frost; David F Tolin Journal: J Obsessive Compuls Relat Disord Date: 2017-06-30 Impact factor: 1.677
Authors: Jay C Fournier; Robert J DeRubeis; Jay Amsterdam; Richard C Shelton; Steven D Hollon Journal: Br J Psychiatry Date: 2014-06-12 Impact factor: 9.319
Authors: Sigal Zilcha-Mano; Harold Chui; Tohar Dolev; Kevin S McCarthy; Ulrike Dinger; Jacques P Barber Journal: J Affect Disord Date: 2015-12-31 Impact factor: 4.839
Authors: Lotte H J M Lemmens; Arnoud Arntz; Frenk P M L Peeters; Steven D Hollon; Anne Roefs; Marcus J H Huibers Journal: Trials Date: 2011-06-14 Impact factor: 2.279
Authors: Marcus J H Huibers; Zachary D Cohen; Lotte H J M Lemmens; Arnoud Arntz; Frenk P M L Peeters; Pim Cuijpers; Robert J DeRubeis Journal: PLoS One Date: 2015-11-10 Impact factor: 3.240